The 22nd Takeda Science Foundation Symposium on Bioscience


*Alphabetical order in each session.

Day 1

Vaccine/Infectious Diseases

Germinal centers, TFH cells, and immunodominance in vaccine immunology
Shane CrottyLa Jolla Institute for Immunology, U.S.A.
Immunology of long COVID
Akiko IwasakiYale School of Medicine, U.S.A.
Clonal dynamics in the steady state and in the immune response
Antonio LanzavecchiaNational Institute of Molecular Genetics, Italy
Systems Vaccinology
Bali PulendranStanford University, U.S.A.
Deconstructing the form and function of T cell responses to pathogens and tumors
Paul G. ThomasSt. Jude Children's Research Hospital, U.S.A.


A Single Cell View of the Infant Immune System
Jacques Banchereau Immunai, U.S.A.
Systems immunology of human immune set points
John S. TsangYale School of Medicine, U.S.A.
Genomics and multi-omics studies to understand human immune system
Kazuhiko YamamotoRIKEN Center for Integrative Medical Sciences, Japan

Resident Immune Cells in Human Organs

Tissue and age determinants of the human immune system
Donna Farber Columbia University, U.S.A.
Regulation of IL-15-induced bystander CD8+ T cell activation
Eui‐Cheol Shin Korea Advanced Institute of Science and Techonology (KAIST), Korea
The human liver immune system
Hideki UenoKyoto University, Japan

Day 2

Primary Immunodeficiency / Autoimmune Diseases

Human genetic and immunological determinants of infectious diseases
Jean-Laurent CasanovaThe Rockefeller University, U.S.A.
Human Immune Organoids to understand vaccination and autoimmunity
Mark Davis Stanford University School of Medicine, U.S.A.
Systemic Lupus Erythematosus: Interferon and Beyond
Virginia PascualWeill Cornell Medical College, U.S.A.
Defining genetic mechanisms of autoimmunity
Soumya RaychaudhuriHarvard Medical School, U.S.A.
T cell activation, differentiation and immune regualation
Federica SallustoETH Zurich, Switzerland

Cancer Immunology

Epigenetic control of immune responses
Sebastian AmigorenaMemorial Sloan Kettering Cancer Center, France
Immuno-genomic cancer evolution governs immune landscapes in the tumor microenvironment
Hiroyoshi NishikawaNational Cancer Center / Nagoya University, Japan
Cancer rearranges the rules in tissue building blocks. A new class of targets for therapy?
Garry NolanStanford Medicine, U.S.A.
Antigen sensitivity, logic gating and persistence of CAR T cells
Michel SadelainMemorial Sloan Kettering Cancer Center, U.S.A.
Novel checkpoints in T cells and APCs
Weiping ZouUniversity of Michigan, U.S.A.
Poster Download[PDF:約743KB]


Takeda Science Foundation
2-3-6 Doshomachi, Chuo-ku, Osaka


c/o Congress Corporation
3-1 Ofuka-cho, Kita-ku, Osaka
530-0011 Grand Front Osaka